Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Nichi-iko Strengthening Customer Relations, Distribution System
July 24, 2006
- MEDICAL DEVICE NEWS IN BRIEF
July 24, 2006
- Sandoz K.K. Aims for Sharp Increase in Sales by 2010
July 24, 2006
- NEW PRODUCTS
July 24, 2006
- BUSINESS NEWS IN BRIEF
July 24, 2006
- REGULATORY NEWS IN BRIEF
July 24, 2006
- Ryukaikon Should Settle Old Problems before Tackling New Ones: JPMA
July 24, 2006
- InCROM Increases Number of Beds for Clinical Trials
July 24, 2006
- Bushu Aims to Become No. 1 Contract Drug Maker in Japan
July 24, 2006
- Astellas to Promote Vesicare as 1st Choice OAB Treatment
July 24, 2006
- SUEVEY
July 24, 2006
- Teijin Pharma to Focus on New Drug Development in the US, Europe
July 24, 2006
- PII Study on Implanted Cardiac Assist Device Initiated
July 24, 2006
- Torrent Seeks Alliances with Japanese Companies
July 24, 2006
- Annual NHI Price Revision Would Cause Confusion: Mr Henmi of Nichibyokyo
July 24, 2006
- Sysmex America Receives Premier Pinnacle Award
July 24, 2006
- SEMINAR
July 17, 2006
- 116 Ingredients/402 Products Added in GE Drug Listing
July 17, 2006
- Taiyo Has Most GE Drugs Listed for 11th Year in a Row
July 17, 2006
- Most Generics Listed in 2006 Available in All Specifications
July 17, 2006
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…